Phillips J C, Mendis D, Gaunt I F
British Industrial Biological Research Association, Carshalton, Surrey, England.
Food Chem Toxicol. 1987 Dec;25(12):1013-9. doi: 10.1016/0278-6915(87)90297-3.
The absorption, metabolism, tissue distribution and excretion of 14C-labelled Brown HT has been studied in the rat, mouse and guinea-pig. Following administration of a single oral dose of either 50 or 250 mg Brown HT/kg, substantially all of the dose was excreted in the urine and faeces within 72 hr, with the majority (more than 80%) being accounted for in the faeces. A significant difference in urinary excretion of radioactivity was seen between male and female rats, as well as clear species differences at the two dose levels used. In all species studied, naphthionic acid was the major urinary metabolite, whereas in the faeces naphthionic acid, trace quantities of unchanged dye and at least two unidentified metabolites were found. Pregnant rats eliminated a single oral dose of 14C-labelled colouring at a rate similar to that in non-pregnant females, but some retention of radioactivity was found in the foetuses. Radioactivity was present in all tissues of male rats 24 hr after an oral dose of 250 mg 14C-labelled Brown HT/kg, with the highest concentrations in the gastro-intestinal tract, kidney and lymph nodes. Clearance from the gastro-intestinal tract was more rapid than from other tissues, but by day 7, the concentration of radioactivity (less than 0.001% of the dose/g) was similar in all tissues except the kidney and mesenteric lymph nodes. Similar results were obtained with animals pretreated for 21 days with either unlabelled or 14C-labelled Brown HT (250 mg/kg/day) prior to a radioactive dose. For most tissues examined, the concentration of radioactivity was greater with pretreatment than without. These results suggest that despite the rapid reduction and elimination of the major part of an oral dose of Brown HT, some colouring and/or metabolites accumulate in most tissues of male rats during repeated daily administration, but that only in the kidney and mesenteric lymph nodes is the accumulation tissue-specific. The accumulated radioactivity is cleared rapidly from most tissues on cessation of treatment. No significant absorption of either Brown HT, metabolites or subsidiary dyes was detected using isolated loops of small intestine.
已在大鼠、小鼠和豚鼠中研究了14C标记的布朗HT的吸收、代谢、组织分布和排泄情况。单次口服50或250毫克布朗HT/千克后,基本上所有剂量在72小时内通过尿液和粪便排出,其中大部分(超过80%)通过粪便排出。雄性和雌性大鼠的放射性尿液排泄存在显著差异,在所使用的两个剂量水平上也存在明显的物种差异。在所有研究的物种中,萘乙磺酸是主要的尿液代谢产物,而在粪便中发现了萘乙磺酸、微量未变化的染料和至少两种未鉴定的代谢产物。怀孕大鼠消除单次口服的14C标记色素的速率与未怀孕雌性大鼠相似,但在胎儿中发现了一些放射性物质的滞留。口服250毫克14C标记的布朗HT/千克后24小时,雄性大鼠的所有组织中均存在放射性,胃肠道、肾脏和淋巴结中的浓度最高。胃肠道的清除速度比其他组织快,但到第7天,除肾脏和肠系膜淋巴结外,所有组织中的放射性浓度(低于剂量/克的0.001%)相似。在用未标记或标记14C的布朗HT(250毫克/千克/天)预处理21天,然后给予放射性剂量的动物中也得到了类似的结果。对于大多数检查的组织,预处理后的放射性浓度高于未预处理的情况。这些结果表明,尽管口服剂量的布朗HT大部分迅速减少和消除,但在重复每日给药期间,一些色素和/或代谢产物在雄性大鼠的大多数组织中积累,但只有在肾脏和肠系膜淋巴结中的积累是组织特异性的。停止治疗后,积累的放射性物质从大多数组织中迅速清除。使用分离的小肠肠袢未检测到布朗HT、代谢产物或辅助染料的显著吸收。